These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38367891)

  • 1. Clinical characterization of type 1 long QT syndrome caused by C-terminus Kv7.1 variants.
    Kashiwa A; Itoh H; Makiyama T; Wada Y; Ozawa J; Kato K; Fukuyama M; Nakajima T; Ohno S; Horie M
    Heart Rhythm; 2024 Jul; 21(7):1113-1120. PubMed ID: 38367891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing the Predictive Power of Mutations in the C-Terminus of the KCNQ1-Encoded Kv7.1 Voltage-Gated Potassium Channel.
    Kapplinger JD; Tseng AS; Salisbury BA; Tester DJ; Callis TE; Alders M; Wilde AA; Ackerman MJ
    J Cardiovasc Transl Res; 2015 Apr; 8(3):187-97. PubMed ID: 25854863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese Patients.
    Shimizu W; Makimoto H; Yamagata K; Kamakura T; Wada M; Miyamoto K; Inoue-Yamada Y; Okamura H; Ishibashi K; Noda T; Nagase S; Miyazaki A; Sakaguchi H; Shiraishi I; Makiyama T; Ohno S; Itoh H; Watanabe H; Hayashi K; Yamagishi M; Morita H; Yoshinaga M; Aizawa Y; Kusano K; Miyamoto Y; Kamakura S; Yasuda S; Ogawa H; Tanaka T; Sumitomo N; Hagiwara N; Fukuda K; Ogawa S; Aizawa Y; Makita N; Ohe T; Horie M; Aiba T
    JAMA Cardiol; 2019 Mar; 4(3):246-254. PubMed ID: 30758498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long QT syndrome-associated calmodulin variants disrupt the activity of the slowly activating delayed rectifier potassium channel.
    McCormick L; Wadmore K; Milburn A; Gupta N; Morris R; Held M; Prakash O; Carr J; Barrett-Jolley R; Dart C; Helassa N
    J Physiol; 2023 Sep; 601(17):3739-3764. PubMed ID: 37428651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic characterization of KCNQ1 variants improves risk stratification in type 1 long QT syndrome patients.
    Morgat C; Fressart V; Porretta AP; Neyroud N; Messali A; Temmar Y; Algalarrondo V; Surget E; Bloch A; Leenhardt A; Denjoy I; Extramiana F
    Europace; 2024 Jun; 26(6):. PubMed ID: 38825991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Mechanical Alterations and Genotype Specific Differences in Subjects With Long QT Syndrome.
    Leren IS; Hasselberg NE; Saberniak J; Håland TF; Kongsgård E; Smiseth OA; Edvardsen T; Haugaa KH
    JACC Cardiovasc Imaging; 2015 May; 8(5):501-510. PubMed ID: 25890583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A KCNQ1 mutation contributes to the concealed type 1 long QT phenotype by limiting the Kv7.1 channel conformational changes associated with protein kinase A phosphorylation.
    Bartos DC; Giudicessi JR; Tester DJ; Ackerman MJ; Ohno S; Horie M; Gollob MH; Burgess DE; Delisle BP
    Heart Rhythm; 2014 Mar; 11(3):459-68. PubMed ID: 24269949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics.
    Piippo K; Swan H; Pasternack M; Chapman H; Paavonen K; Viitasalo M; Toivonen L; Kontula K
    J Am Coll Cardiol; 2001 Feb; 37(2):562-8. PubMed ID: 11216980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular diagnostics of families with long-QT syndrome.
    Moric-Janiszewska E; Głowacka M
    Cardiol J; 2012; 19(2):159-67. PubMed ID: 22461049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.
    Moss AJ; Shimizu W; Wilde AA; Towbin JA; Zareba W; Robinson JL; Qi M; Vincent GM; Ackerman MJ; Kaufman ES; Hofman N; Seth R; Kamakura S; Miyamoto Y; Goldenberg I; Andrews ML; McNitt S
    Circulation; 2007 May; 115(19):2481-9. PubMed ID: 17470695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A novel KCNQ1 mutation in Chinese with congenital long QT syndrome].
    Liang L; Du ZD; Cai LL; Wu JX; Zheng T; Qi TX
    Zhonghua Er Ke Za Zhi; 2003 Oct; 41(10):724-7. PubMed ID: 14731347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological phenotype in the LQTS mutations Y111C and R518X in the KCNQ1 gene.
    Diamant UB; Vahedi F; Winbo A; Rydberg A; Stattin EL; Jensen SM; Bergfeldt L
    J Appl Physiol (1985); 2013 Nov; 115(10):1423-32. PubMed ID: 24052033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype- and mutation site-specific QT adaptation during exercise, recovery, and postural changes in children with long-QT syndrome.
    Aziz PF; Wieand TS; Ganley J; Henderson J; Patel AR; Iyer VR; Vogel RL; McBride M; Vetter VL; Shah MJ
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):867-73. PubMed ID: 21956039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.
    Koponen M; Marjamaa A; Hiippala A; Happonen JM; Havulinna AS; Salomaa V; Lahtinen AM; Hintsa T; Viitasalo M; Toivonen L; Kontula K; Swan H
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):815-23. PubMed ID: 26063740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-based clinical manifestation and treatment of Chinese long QT syndrome patients with KCNQ1 mutations - R380S and W305L.
    Zhou H; Lai W; Zhu W; Xie J; Liu X; Shen Y; Yuan P; Liu Y; Cao Q; He W; Hong K
    Cardiol Young; 2016 Apr; 26(4):754-63. PubMed ID: 26344792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Architectural T-Wave Analysis and Identification of On-Therapy Breakthrough Arrhythmic Risk in Type 1 and Type 2 Long-QT Syndrome.
    Sugrue A; Rohatgi RK; Noseworthy PA; Kremen V; Bos JM; Qiang B; Sapir Y; Attia ZI; Scott CG; Brady P; Asirvatham SJ; Friedman PA; Ackerman MJ
    Circ Arrhythm Electrophysiol; 2017 Nov; 10(11):. PubMed ID: 29141844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the genome aggregation database, computational pathogenicity prediction tools, and patch clamp heterologous expression studies to demote previously published long QT syndrome type 1 mutations from pathogenic to benign.
    Clemens DJ; Lentino AR; Kapplinger JD; Ye D; Zhou W; Tester DJ; Ackerman MJ
    Heart Rhythm; 2018 Apr; 15(4):555-561. PubMed ID: 29197658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance.
    Barc J; Briec F; Schmitt S; Kyndt F; Le Cunff M; Baron E; Vieyres C; Sacher F; Redon R; Le Caignec C; Le Marec H; Probst V; Schott JJ
    J Am Coll Cardiol; 2011 Jan; 57(1):40-7. PubMed ID: 21185499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-QT mutation p.K557E-Kv7.1: dominant-negative suppression of IKs, but preserved cAMP-dependent up-regulation.
    Spätjens RL; Bébarová M; Seyen SR; Lentink V; Jongbloed RJ; Arens YH; Heijman J; Volders PG
    Cardiovasc Res; 2014 Oct; 104(1):216-25. PubMed ID: 25139741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation KCNQ1p.Thr312del is responsible for long QT syndrome type 1.
    Chen XM; Guo K; Li H; Lu QF; Yang C; Yu Y; Hou JW; Fei YD; Sun J; Wang J; Li YX; Li YG
    Heart Vessels; 2019 Jan; 34(1):177-188. PubMed ID: 30008122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.